Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Similar articles for PubMed (Select 15923363)

1.

Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue.

Johnson KR, Johnson KY, Crellin HG, Ogretmen B, Boylan AM, Harley RA, Obeid LM.

J Histochem Cytochem. 2005 Sep;53(9):1159-66. Epub 2005 May 27.

PMID:
15923363
2.

De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.

Berdyshev EV, Gorshkova IA, Usatyuk P, Zhao Y, Saatian B, Hubbard W, Natarajan V.

Cell Signal. 2006 Oct;18(10):1779-92. Epub 2006 Mar 10.

PMID:
16529909
3.

Sphingosine kinase 1 is up-regulated in colon carcinogenesis.

Kawamori T, Osta W, Johnson KR, Pettus BJ, Bielawski J, Tanaka T, Wargovich MJ, Reddy BS, Hannun YA, Obeid LM, Zhou D.

FASEB J. 2006 Feb;20(2):386-8. Epub 2005 Nov 30.

4.

Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2.

Anelli V, Gault CR, Cheng AB, Obeid LM.

J Biol Chem. 2008 Feb 8;283(6):3365-75. Epub 2007 Nov 30.

5.

FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.

Hayashi H, Nakagami H, Takami Y, Koriyama H, Mori M, Tamai K, Sun J, Nagao K, Morishita R, Kaneda Y.

Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):909-14. doi: 10.1161/ATVBAHA.108.178541. Epub 2009 Mar 26. Erratum in: Arterioscler Thromb Vasc Biol. 2009 Dec 1;29(12):e132.

6.

Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer.

Zhang S, Qiu X, Gu Y, Wang E.

Lung Cancer. 2008 Dec;62(3):295-301. doi: 10.1016/j.lungcan.2008.05.008. Epub 2008 Jun 20.

PMID:
18571765
7.

Activation of sphingosine kinase-1 mediates inhibition of vascular smooth muscle cell apoptosis by hyperglycemia.

You B, Ren A, Yan G, Sun J.

Diabetes. 2007 May;56(5):1445-53. Epub 2007 Feb 26.

8.

Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.

Yan G, Chen S, You B, Sun J.

Cardiovasc Res. 2008 May 1;78(2):308-14. doi: 10.1093/cvr/cvn006. Epub 2008 Jan 10.

9.

Stratification of sphingosine kinase-1 expression and activity in rat kidney.

Facchinetti MM, Leocata Nieto F, Márquez MG, Sterin-Speziale N.

Cells Tissues Organs. 2008;188(4):384-92. doi: 10.1159/000139770. Epub 2008 Jun 13.

PMID:
18552482
10.

Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.

Schnitzer SE, Weigert A, Zhou J, Brüne B.

Mol Cancer Res. 2009 Mar;7(3):393-401. doi: 10.1158/1541-7786.MCR-08-0156. Epub 2009 Feb 24.

11.

Effect of a membrane-targeted sphingosine kinase 1 on cell proliferation and survival.

Safadi-Chamberlain F, Wang LP, Payne SG, Lim CU, Stratford S, Chavez JA, Fox MH, Spiegel S, Summers SA.

Biochem J. 2005 Jun 15;388(Pt 3):827-34.

12.

A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.

Paugh SW, Paugh BS, Rahmani M, Kapitonov D, Almenara JA, Kordula T, Milstien S, Adams JK, Zipkin RE, Grant S, Spiegel S.

Blood. 2008 Aug 15;112(4):1382-91. doi: 10.1182/blood-2008-02-138958. Epub 2008 May 29.

13.

Activity and tissue localization of cathepsin D in non small cell lung cancer.

Chyczewski L, Płoński A, Chyczewska E, Furman M, Ostrowska H, Nikliński J, Kozłowski M.

Rocz Akad Med Bialymst. 1997;42 Suppl 1:217-29.

PMID:
9337539
14.

Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.

Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Hsu LH, Wu CW, Ting CC, Chen CY, Chen KC, Yang TY, Chou TY, Wang WH, Whang-Peng J, Shih NY.

Clin Cancer Res. 2006 Oct 1;12(19):5746-54.

15.

ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.

Migita T, Narita T, Nomura K, Miyagi E, Inazuka F, Matsuura M, Ushijima M, Mashima T, Seimiya H, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y.

Cancer Res. 2008 Oct 15;68(20):8547-54. doi: 10.1158/0008-5472.CAN-08-1235.

16.

Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation.

Lavieu G, Scarlatti F, Sala G, Carpentier S, Levade T, Ghidoni R, Botti J, Codogno P.

J Biol Chem. 2006 Mar 31;281(13):8518-27. Epub 2006 Jan 16.

17.

[Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].

Zhang J, Xu YJ, Zhang ZX, DU CL, Qiao LF, Ni W, Chen SX.

Zhonghua Jie He He Hu Xi Za Zhi. 2007 Oct;30(10):771-5. Chinese.

PMID:
18218209
18.

Defining a role for sphingosine kinase 1 in p53-dependent tumors.

Heffernan-Stroud LA, Helke KL, Jenkins RW, De Costa AM, Hannun YA, Obeid LM.

Oncogene. 2012 Mar 1;31(9):1166-75. doi: 10.1038/onc.2011.302. Epub 2011 Jul 18.

19.

Relationship between matrix metalloproteinase 2 and lung cancer progression.

Guo CB, Wang S, Deng C, Zhang DL, Wang FL, Jin XQ.

Mol Diagn Ther. 2007;11(3):183-92.

PMID:
17570740
20.

Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells.

Limaye V, Xia P, Hahn C, Smith M, Vadas MA, Pitson SM, Gamble JR.

Cell Mol Biol Lett. 2009;14(3):424-41. doi: 10.2478/s11658-009-0009-1. Epub 2009 Feb 23.

PMID:
19238330
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk